Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niaspan in Subacute Ischemic Stroke Recovery
NCT00796887Phase 2Terminated
- Sponsor
- Henry Ford Health
- Start
- Apr 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niacin in ischemic stroke, sponsored by Henry Ford Health. Started Apr 2009; status: terminated.
02
Drugs
niacin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00796887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796887.